Notably, cytotoxicity against RCC tumor cells was significantly reduced upon blockade of key NKRs (e.g., NKG2D and DNAM-1), confirming the contribution of NKR-mediated tumor recognition (Figures 3H and 3I). Here, CD226 is linked to neoplasm.